Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;74(2):586-591.
doi: 10.1016/j.jvs.2020.12.097. Epub 2021 Feb 4.

Surgical outcomes and factors associated with malignancy in carotid body tumors

Affiliations
Free article

Surgical outcomes and factors associated with malignancy in carotid body tumors

Wei Zhang et al. J Vasc Surg. 2021 Aug.
Free article

Abstract

Objective: To compare the surgical outcomes of benign and malignant carotid body tumor (CBT), and to evaluate the associated factors of malignant CBT.

Methods: Patients who underwent surgical resection of CBT from 2005 to 2018 in a tertiary center were reviewed retrospectively. The common study follow-up end date was December 31, 2019. The tumor size was measured as the maximum transverse diameter on computed tomography scan. Surgical outcomes of benign and malignant CBT were compared. Associated factors of malignancy were analyzed by multivariate logistic analysis.

Results: There were 229 patients undergoing CBT resection. Sixteen patients were diagnosed with malignant CBT. The median follow-up time was 66 months (range, 6-142 months). Basic information including age, sex, course of disease, family history, lesion side, tumor size, and Shamblin classification showed no significant differences between the benign and malignant CBT groups. Patients with malignant CBTs showed a higher rate of preoperative symptoms (31.3% vs 12.2%; P < .05). The rates of vascular reconstruction or repair (P < .01) and neurologic complications (P < .05) were significantly higher in the malignant CBT group. In addition, a significantly longer average procedural time was required for malignant CBTs (P < .05). However, the estimated blood loss and length of hospital stay showed no significant difference. Multivariate logistic regression analysis revealed that the malignant odds of CBT with bilateral lesions (P = .0042; odds ratio, 8.30; 95% confidence interval, 1.84-35.88) or CBT with preoperative symptoms (P = .0016; odds ratio, 7.59; 95% confidence interval, 2.13-27.89) were high.

Conclusions: Compared with benign CBT, malignant CBT is prone to invasive clinical behaviors, resulting in an increased possibility of vascular reconstruction or repair during the surgery as well as postoperative neurologic complications. In addition, the malignant odds of CBT with bilateral lesions or CBT with preoperative symptoms are high.

Keywords: Carotid body tumor; Malignancy; Surgical outcomes.

PubMed Disclaimer

Comment in

  • Reply.
    Zhang W, Wang L. Zhang W, et al. J Vasc Surg. 2022 Jan;75(1):386-387. doi: 10.1016/j.jvs.2021.09.018. J Vasc Surg. 2022. PMID: 34949388 No abstract available.
  • Carotid paraganglioma patients should be tested for gene mutations.
    Cohnert T, Konstantiniuk P. Cohnert T, et al. J Vasc Surg. 2022 Jan;75(1):386. doi: 10.1016/j.jvs.2021.08.088. J Vasc Surg. 2022. PMID: 34949389 No abstract available.

Publication types

MeSH terms

LinkOut - more resources